Insider filing · MIRM
Laura Brege
Director
profile →
Mirum Pharmaceuticals, Inc.
MIRM · Healthcare · 60 filings in 24 months
ticker →
Laura Brege sold $1.3M of Mirum Pharmaceuticals (MIRM)
Executed Sep 11 2025, disclosed Sep 12 2025, 1 day later.
Value, as filed
$1.3M
17,000 sh across 2 lots
Executed
Sep 11 2025
the trade date, as filed
Disclosed
Sep 12 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LBLaura Brege (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $1.3M of MIRM (17,000 sh across 2 lots, as filed), executed Sep 11 2025.
The name
MIRMHealthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→